» Articles » PMID: 35628612

Histone Modifications and Non-Coding RNAs: Mutual Epigenetic Regulation and Role in Pathogenesis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 May 28
PMID 35628612
Authors
Affiliations
Soon will be listed here.
Abstract

In the last few years, more and more scientists have suggested and confirmed that epigenetic regulators are tightly connected and form a comprehensive network of regulatory pathways and feedback loops. This is particularly interesting for a better understanding of processes that occur in the development and progression of various diseases. Appearing on the preclinical stages of diseases, epigenetic aberrations may be prominent biomarkers. Being dynamic and reversible, epigenetic modifications could become targets for a novel option for therapy. Therefore, in this review, we are focusing on histone modifications and ncRNAs, their mutual regulation, role in cellular processes and potential clinical application.

Citing Articles

Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways.

Kaszycki J, Kim M Front Immunol. 2025; 16:1529756.

PMID: 40046056 PMC: 11879833. DOI: 10.3389/fimmu.2025.1529756.


Deciphering the epigenetic role of long non-coding RNAs in mood disorders: Focus on human brain studies.

Roy B, Verma A, Funahashi Y, Dwivedi Y Clin Transl Med. 2025; 15(3):e70135.

PMID: 40038891 PMC: 11879898. DOI: 10.1002/ctm2.70135.


Glucocorticoid receptor epigenetic activity in the heart.

Akinborewa O, Quattrocelli M Epigenetics. 2025; 20(1):2468113.

PMID: 40007064 PMC: 11866966. DOI: 10.1080/15592294.2025.2468113.


Molecular Mechanisms of Immune Regulation: A Review.

Arneth B Cells. 2025; 14(4).

PMID: 39996755 PMC: 11853995. DOI: 10.3390/cells14040283.


Therapeutic Potential of FTO Demethylase in Metabolism and Disease Pathways.

Somala C, Sathyapriya S, Bharathkumar N, Anand T, Mathangi D, Saravanan K Protein J. 2025; 44(1):21-34.

PMID: 39923206 DOI: 10.1007/s10930-025-10250-3.


References
1.
Inoue F, Sone K, Toyohara Y, Takahashi Y, Kukita A, Hara A . Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications. Int J Mol Sci. 2021; 22(5). PMC: 7956745. DOI: 10.3390/ijms22052305. View

2.
Xia K, Yu L, Huang X, Zhao Z, Liu J . Epigenetic regulation by long noncoding RNAs in osteo-/adipogenic differentiation of mesenchymal stromal cells and degenerative bone diseases. World J Stem Cells. 2022; 14(1):92-103. PMC: 8788182. DOI: 10.4252/wjsc.v14.i1.92. View

3.
Pan W, Zhang N, Liu W, Liu J, Zhou L, Liu Y . The long noncoding RNA suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor . J Biol Chem. 2018; 293(44):17154-17165. PMC: 6222094. DOI: 10.1074/jbc.RA118.003055. View

4.
Li Z, Yu D, Li H, Lv Y, Li S . Long non‑coding RNA UCA1 confers tamoxifen resistance in breast cancer endocrinotherapy through regulation of the EZH2/p21 axis and the PI3K/AKT signaling pathway. Int J Oncol. 2019; 54(3):1033-1042. DOI: 10.3892/ijo.2019.4679. View

5.
Zhang J, Li W, Yang Y, Yan L, Zhang S, He J . LncRNA XIST facilitates cell growth, migration and invasion via modulating H3 histone methylation of DKK1 in neuroblastoma. Cell Cycle. 2019; 18(16):1882-1892. PMC: 6681787. DOI: 10.1080/15384101.2019.1632134. View